Patents and Competitive Dynamics in the Indian Pharma Industry

Anand, M and Nandkumar, A (2015) Patents and Competitive Dynamics in the Indian Pharma Industry. [Teaching Resource]

Full text not available from this repository. (Request a copy)

Abstract

This case describes the challenges pharmaceutical multinational corporations (MNCs) face in understanding and navigating the intricacies of patent law in India and what they can learn from key pharmaceutical intellectual property (IP) cases being fought in the nation's courts. Like most emerging markets, India is both an exciting new market opportunity for MNCs and a challenging and complex environment in which to operate. For instance, while the patent protection afforded to products and processes is stringent, at least on paper, its enforcement has often been problematic for MNCs and has thwarted MNCs efforts to operate profitably in India. The case study discusses some of the recent judgments handed down by the Indian courts in high-profile pharmaceutical IP cases (such as Novartis' Glivec and Bayer's Nexavar) with a view to helping students formulate strategies to overcome value appropriation problems in India.

Affiliation: Indian School of Business
ISB Creators:
ISB CreatorsORCiD
Nandkumar, AUNSPECIFIED
Item Type: Teaching Resource
Uncontrolled Keywords: Competition, International business
Subjects: Information Systems
Depositing User: Ilayaraja M
Date Deposited: 04 Jul 2019 14:20
Last Modified: 04 Jul 2019 14:20
URI: http://eprints.exchange.isb.edu/id/eprint/1238
Publisher URL: https://hbr.org/product/patents-and-competitive-dy...
Publisher OA policy: https://hbr.org/product/patents-and-competitive-dy...
Related URLs:

    Actions (login required)

    View Item View Item
    Statistics for DESI ePrint 1238 Statistics for this ePrint Item